📇 Rhumatologue ·

M JEAN-LOUIS KUNTZ

Pourquoi vous devez consulter ce praticien

2 raisons identifiées

Auteur de référence en rhumatologie
34 articles scientifiques publiés — un praticien à la pointe de la recherche
Encadrant universitaire
Forme la prochaine génération de rhumatologues (4 thèses dirigées)

Rhumatologue

RPPS 10001701373

Enseignement

📊 Reconnaissance scientifique : 12/100📝 25 articles publiés🎓 4 thèses dirigées

✨ Génération du profil synthétique IA en cours…

Direction de thèses

🎓 4 thèses dirigées

Traitement des myopathies inflammatoires de l'adulte : intérêt des immunoglobulines humaines polyvalentes par voie intra-veineuse : à propos de trois observations

Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.

Top publications · les plus citées

Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3 x 400 mg/day vs placebo

Osteoarthritis and cartilage · 1998

📚 83 citations🎯 RCR 2.88Top 17% NIH🩺 Clinique🔓 Open Access📄 PDF gratuit ↗

Bisphosphonate Drug Holiday and Fracture Risk: A Population-Based Cohort Study

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2018

📚 79 citations🎯 RCR 4.61Top 9% NIH

Lire l'abstract Crossref ↓

ABSTRACT Holidays from bisphosphonates (BPs) may help to prevent rare adverse events such as atypical femoral fractures, but may be appropriate only if risk of osteoporosis-related fractures does not increase. Our objective was to compare the incidence of osteoporosis-related fractures among women who had a BP holiday to those who continued to use BPs. This retrospective cohort study, conducted within four Kaiser Permanente integrated health system regions, included 39,502 women aged ≥45 years with ≥3 years exposure to BP. Participants with a BP holiday (≥12 months with no use) were compared to persistent (use with ≥50% adherence) and nonpersistent (use with &lt;50% adherence) users for incident osteoporosis-related fractures. The BP holiday (n = 11,497), nonpersistent user (n = 10,882), and persistent user groups (n = 17,123) were observed for 156,657 person-years. A total of 5199 osteoporosis-related fractures (including 1515 hip fractures and 2147 vertebral fractures) were observed. Compared to the persistent use group, there was a slight difference in overall osteoporosis-related fracture risk (HR 0.92; 95% CI, 0.84 to 0.99)and no difference in hip fracture risk (HR 0.95; 95% CI, 0.83 to 1.10) for the BP holiday group. A slight reduction in risk of vertebral fracture was observed (HR 0.83; 95% CI, 0.74 to 0.95). Compared to the nonpersistent user group, the BP holiday group was at decreased risk for osteoporosis-related fractures (HR 0.71; 95% CI, 0.65 to 0.79), vertebral fractures (HR 0.68; 95% CI, 0.59 to 0.78), and hip fractures (HR 0.59; 95% CI, 0.50 to 0.70). Women who undertake a BP holiday from BP of ≥12 months duration for any reason after ≥3 years of BP use do not appear to be at greater risk of osteoporosis-related fragility fracture, hip, or vertebral fractures compared to ongoing BP users. In our cohort, BP holiday remains a viable strategy for balancing the benefits and potential harms associated with long-term BP use. © 2018 American Society for Bone and Mineral Research.

Sulphasalazine in psoriatic arthritis: a randomized, multicentre, placebo-controlled study

British journal of rheumatology · 1996

📚 74 citations🎯 RCR 2.79Top 18% NIH🩺 Clinique🔓 Open Access📄 PDF gratuit ↗

Cookies & analyse de trafic

M JEAN-LOUIS KUNTZ

Pourquoi vous devez consulter ce praticien

Direction de thèses

Activité de recherche & publications

Lieu de consultation

Tarifs & secteur de conventionnement

Prendre rendez-vous & contact

Top publications · les plus citées

Publications scientifiques (34) — classées par pathologie

Transversal25

csDMARDs3

Essai clinique3

Anti-TNF1

Case report / série1

Lombalgie1

Ostéoporose1

Partager cette fiche